Not responsive to the question asked
- Forums
- ASX - By Stock
- MYX
- News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.00

News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
0.000(0.00%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$5.03 | $5.03 | $4.99 | $168.6K | 33.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2131 | $4.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.01 | 598 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1508 | 5.000 |
2 | 1123 | 4.990 |
2 | 1098 | 4.980 |
3 | 1281 | 4.970 |
3 | 2098 | 4.960 |
Price($) | Vol. | No. |
---|---|---|
5.030 | 2340 | 8 |
5.040 | 17751 | 14 |
5.050 | 2529 | 4 |
5.060 | 16673 | 5 |
5.070 | 8450 | 2 |
Last trade - 10.57am 03/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online